Calcilytix receives data that cannot be directly linked to you from this program, but at no time will Calcilytix receive patient-identifiable information.
Calcilytix uses the de-identified patient data for research and commercial purposes, including:
Improving the understanding of hypoparathyroidism epidemiology and clinical presentation
Understanding the burden of illness for genetic causes of hypoparathyroidism
Identifying potential clinical trial candidates through their providers
